GREY:EDYYF - Post by User
Comment by
Hejhogon Jan 08, 2019 11:04pm
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
68 Views
Post# 29203947
RE:RE:RE:RE:RE:RE:RE:CEAU specs
RE:RE:RE:RE:RE:RE:RE:CEAU specsYou could be right. But, there is a big piece of the information puzzle that is missing.
I am inferring that Hifarm does not have a license to produce (It certainly isn't listed).
The original NR advised that EHT was chosen to supply the units (to the North Bay facility) for reasons that included speed of delivery.
Do we infer that it is taking longer than they imagined it would take for Hifarm to get a license?
And they are now loaning out the product for testing to a different licensed producer? That is, EHT delivered on time but HiFarm can't accept the product for its intended use yet.
Or, do we infer that Hifarm did not successfully negotiate "agreements to supply medical grade cannabis to academic, medical, and distribution partners for research and sales in Ontario" as was reported in the original MJ NR?
Are these initial units going to be subject to the origial supply agreement or are they now proof of concept for a different business plan (such as to sell to third party licensed producers).
Is this money gone or money in the bank or future revenue. How does EHT get dollars out of these initial units?
Can they please let me write the NRs from now on!